Your browser doesn't support javascript.
loading
SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India.
Doke, Prakash P; Mhaske, Suhas T; Oka, Gauri; Kulkarni, Ruta; Muley, Vrishali; Mishra, Akhilesh Chandra; Arankalle, Vidya A.
  • Doke PP; Department of Community Medicine, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India.
  • Mhaske ST; Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India.
  • Oka G; Department of Community Medicine, Bharati Vidyapeeth (Deemed to be University) Medical College, Pune, India.
  • Kulkarni R; Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India.
  • Muley V; Department of Microbiology, Smt. Kashibai Navale Medical College, Pune, India.
  • Mishra AC; Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India.
  • Arankalle VA; Department of Communicable Diseases, Interactive Research School for Health Affairs (IRSHA), Bharati Vidyapeeth (Deemed to be University), Pune, India.
Front Public Health ; 10: 1040012, 2022.
Article en En | MEDLINE | ID: mdl-36711329

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article